Economy
The Iranian regime has managed to smuggle at least $1 billion to its terrorist proxy Hezbollah in Lebanon despite heavy sanctions this year, top...
Hi, what are you looking for?
Senate Republicans unveiled a crucial piece of the puzzle in their bid to reopen the government and plan to plow ahead with a vote...
The Iranian regime has managed to smuggle at least $1 billion to its terrorist proxy Hezbollah in Lebanon despite heavy sanctions this year, top...
Republican Rep. Riley Moore said the United States could take a range of actions — including sanctions and ‘even kinetic military action’ — in...
The Republican National Committee has expanded legal challenges to voting and election procedures in key swing states since March, when presumptive nominee Donald Trump...
President Biden’s performance at the NATO summit this week is under close scrutiny not only by leaders of the Western alliance but by Democratic...
George Stephanopoulos, the ABC news anchor who recently interviewed President Biden about his fitness for the presidential race, was caught on camera Tuesday indicating...
Donald Trump returned to the campaign trail with a new stump speech that made roughly equal work of skewering President Biden and Vice President...
As President Biden prepared to address NATO allies gathered in Washington on Tuesday evening, his advocates on Capitol Hill seemed to be growing a...
LAS VEGAS — Vice President Harris on Tuesday afternoon offered a full-throated defense of President Biden as he continues to fight for his reelection...
Not a worthy business partner. “Unfit” for the White House. “Con artist.” These are not the words of Democrats attacking Donald Trump, but comments...
Culpeo Minerals Limited (Culpeo or the Company) (ASX:CPO, OTCQB:CPORF) is pleased to announce the change in substantial holding. Click here for the full ASX...
Adisyn Ltd (ASX: AI1) (“Adisyn” or the “Company’) is pleased to announce the following outcomes of the Strategic Review process (ASX: 28 February 2024)....
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...